Phase 1 Gynecologic Clinical Trials
12 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–12 of 12 trials
Recruiting
Phase 1
Brodalumab in the Treatment of Immune-Related Adverse Events
Breast CancerLiver CancerEsophageal Cancer+15 more
Brian Henick, MD11 enrolled1 locationNCT06673329
Recruiting
Phase 1Phase 2
Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
Endometrial CancerCarcinomaGynecologic Cancer+1 more
University of Alabama at Birmingham37 enrolled1 locationNCT05559879
Recruiting
Phase 1
Novel Imaging Technique to Assess Gynecologic Cancer
Gynecologic Cancer
Memorial Sloan Kettering Cancer Center20 enrolled3 locationsNCT04893434
Recruiting
Phase 1
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
Breast CancerGynecologic Cancers
Oregon State University60 enrolled3 locationsNCT07055854
Recruiting
Phase 1
The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies
Cervical CancerEndometrial CancerGynecologic Malignancies
Tongji Hospital97 enrolled1 locationNCT06552598
Recruiting
Phase 1
Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
Gynecological Cancers
University Health Network, Toronto24 enrolled1 locationNCT06977126
Recruiting
Phase 1
A Study of GC203 TIL in Advanced Malignant Solid Tumors
Breast CancerLung CancerSolid Tumor+2 more
Shanghai Juncell Therapeutics18 enrolled1 locationNCT06375187
Recruiting
Phase 1
Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Ovarian CancerGynecologic CancerFallopian Tube Cancer+1 more
Masonic Cancer Center, University of Minnesota33 enrolled1 locationNCT06342986
Recruiting
Phase 1Phase 2
A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors
Tumours, Gynecological
GlaxoSmithKline392 enrolled56 locationsNCT06796907
Recruiting
Phase 1Phase 2
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Solid TumorGynecological Malignant Tumor
Sichuan Baili Pharmaceutical Co., Ltd.38 enrolled1 locationNCT05803018
Recruiting
Phase 1Phase 2
A Study of BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies
Gynecological Malignancies
Sichuan Baili Pharmaceutical Co., Ltd.138 enrolled1 locationNCT06131450
Recruiting
Phase 1
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer
Ovarian CancerMetastatic CancerAdvanced Cancer+2 more
Chongqing Precision Biotech Co., Ltd36 enrolled1 locationNCT06215950